BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 17478737)

  • 21. Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers.
    Montaner J; Perea-Gainza M; Delgado P; Ribó M; Chacón P; Rosell A; Quintana M; Palacios ME; Molina CA; Alvarez-Sabín J
    Stroke; 2008 Aug; 39(8):2280-7. PubMed ID: 18535284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pretreatment hemostatic markers of symptomatic intracerebral hemorrhage in patients treated with tissue plasminogen activator.
    Cocho D; Borrell M; Martí-Fàbregas J; Montaner J; Castellanos M; Bravo Y; Molina-Porcel L; Belvís R; Díaz-Manera JA; Martínez-Domeño A; Martínez-Lage M; Millán M; Fontcuberta J; Martí-Vilalta JL
    Stroke; 2006 Apr; 37(4):996-9. PubMed ID: 16497981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke.
    Ning M; Furie KL; Koroshetz WJ; Lee H; Barron M; Lederer M; Wang X; Zhu M; Sorensen AG; Lo EH; Kelly PJ
    Neurology; 2006 May; 66(10):1550-5. PubMed ID: 16717217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of modified Buyang Huanwu Decoction on hemorrhagic transformation after rt-PA intravenous thrombolysis in patients with super early cerebral infarction].
    Lu YK; Yang HY; Liu XZ; Wang YH; Yang JH
    Zhongguo Zhong Yao Za Zhi; 2019 Apr; 44(8):1696-1703. PubMed ID: 31090337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low Levels of Caveolin-1 Predict Symptomatic Bleeding After Thrombolytic Therapy in Patients With Acute Ischemic Stroke.
    Castellanos M; van Eendenburg C; Gubern C; Kádár E; Huguet G; Puig J; Sobrino T; Blasco G; Serena J; Sánchez JM
    Stroke; 2018 Jun; 49(6):1525-1527. PubMed ID: 29712879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage.
    Silva Y; Leira R; Tejada J; Lainez JM; Castillo J; Dávalos A;
    Stroke; 2005 Jan; 36(1):86-91. PubMed ID: 15550687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood Biomarkers for the Early Diagnosis of Stroke: The Stroke-Chip Study.
    Bustamante A; López-Cancio E; Pich S; Penalba A; Giralt D; García-Berrocoso T; Ferrer-Costa C; Gasull T; Hernández-Pérez M; Millan M; Rubiera M; Cardona P; Cano L; Quesada H; Terceño M; Silva Y; Castellanos M; Garces M; Reverté S; Ustrell X; Marés R; Baiges JJ; Serena J; Rubio F; Salas E; Dávalos A; Montaner J
    Stroke; 2017 Sep; 48(9):2419-2425. PubMed ID: 28716979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A higher body temperature is associated with haemorrhagic transformation in patients with acute stroke untreated with recombinant tissue-type plasminogen activator (rtPA).
    Leira R; Sobrino T; Blanco M; Campos F; Rodríguez-Yáñez M; Castellanos M; Moldes O; Millán M; Dávalos A; Castillo J
    Clin Sci (Lond); 2012 Feb; 122(3):113-9. PubMed ID: 21861843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammation markers and prediction of post-stroke vascular disease recurrence: the MITICO study.
    Castillo J; Alvarez-Sabín J; Martínez-Vila E; Montaner J; Sobrino T; Vivancos J;
    J Neurol; 2009 Feb; 256(2):217-24. PubMed ID: 19252763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological signatures of brain damage associated with high serum ferritin levels in patients with acute ischemic stroke and thrombolytic treatment.
    Millán M; Sobrino T; Arenillas JF; Rodríguez-Yáñez M; García M; Nombela F; Castellanos M; de la Ossa NP; Cuadras P; Serena J; Castillo J; Dávalos A
    Dis Markers; 2008; 25(3):181-8. PubMed ID: 19096131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet derived growth factor-CC isoform is associated with hemorrhagic transformation in ischemic stroke patients treated with tissue plasminogen activator.
    Rodríguez-González R; Blanco M; Rodríguez-Yáñez M; Moldes O; Castillo J; Sobrino T
    Atherosclerosis; 2013 Jan; 226(1):165-71. PubMed ID: 23218119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
    Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
    Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stroke biomarkers: Can they help us to guide stroke thrombolysis?
    Montaner J
    Drug News Perspect; 2006 Nov; 19(9):523-32. PubMed ID: 17220957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Symptomatic intracerebral hemorrhage after intravenous thrombolysis in Chinese patients: comparison of prediction models.
    Li M; Wang-Qin RQ; Wang YL; Liu LB; Pan YS; Liao XL; Wang YJ; Xu AD
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1235-43. PubMed ID: 25891755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum tight-junction proteins predict hemorrhagic transformation in ischemic stroke patients.
    Kazmierski R; Michalak S; Wencel-Warot A; Nowinski WL
    Neurology; 2012 Oct; 79(16):1677-85. PubMed ID: 22993287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A large screening of angiogenesis biomarkers and their association with neurological outcome after ischemic stroke.
    Navarro-Sobrino M; Rosell A; Hernández-Guillamon M; Penalba A; Boada C; Domingues-Montanari S; Ribó M; Alvarez-Sabín J; Montaner J
    Atherosclerosis; 2011 May; 216(1):205-11. PubMed ID: 21324462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Very low cerebral blood volume predicts parenchymal hematoma in acute ischemic stroke.
    Hermitte L; Cho TH; Ozenne B; Nighoghossian N; Mikkelsen IK; Ribe L; Baron JC; Østergaard L; Derex L; Hjort N; Fiehler J; Pedraza S; Hermier M; Maucort-Boulch D; Berthezène Y
    Stroke; 2013 Aug; 44(8):2318-20. PubMed ID: 23723309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke.
    Koga M; Arihiro S; Miyashita F; Yamamoto H; Yamada N; Nagatsuka K; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2013; 36(4):299-305. PubMed ID: 24135558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum Matrix Metalloproteinase-9 and Cognitive Impairment After Acute Ischemic Stroke.
    Zhong C; Bu X; Xu T; Guo L; Wang X; Zhang J; Cui Y; Li D; Zhang J; Ju Z; Chen CS; Chen J; Zhang Y; He J
    J Am Heart Assoc; 2018 Jan; 7(1):. PubMed ID: 29306898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fibrinogen concentration in the evaluation of safety and efficiency of thrombolytic therapy in patients with ischemic stroke].
    Liang OV; Kochetov AG; Shamalov NA; Anisimov KV; Ramazanov GR; Arkhipkin AA; Novozhenova IuV; Kustova MA; Podshivalov DC; Egorov VO
    Ter Arkh; 2012; 84(10):42-7. PubMed ID: 23227499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.